Assure to Participate in the Lake Street 5th Annual Best Ideas Growth (BIG5) Conference
DENVER, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH; OTCQB: ARHHD*),...
Day: September 13, 2021
PDS Biotechnology to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
FLORHAM PARK, N.J., Sept. 13, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel...
SCYNEXIS Announces Hansoh Pharma’s Application to National Medical Products Administration (NMPA) in China for Phase 3 Trial of Ibrexafungerp for Treatment of Vulvovaginal Candidiasis (VVC)
Submission is part of the Hansoh Pharma licensing agreement and strategic partnership to research, develop and commercialize ibrexafungerp in the...
SmileDirectClub Supports Afghan Refugees With Donation of Oral Health Essentials
International Oral Care Leader Announces Year-Long Partnership with International Rescue CommitteeNASHVILLE, Tenn., Sept. 13, 2021 (GLOBE NEWSWIRE) -- SmileDirectClub, the...
LifeMD Appoints Seasoned Investor Naveen Bhatia to Board of Directors
Industry veteran brings deep financial and management expertise to LifeMD as company continues to transform healthcare and build out growing...
ABVC BioPharma Completes Site Selection for ABV-1505 ADHD Phase II Part 2 Clinical Study
Completion of the Study Expected by the End of 2022 FREMONT, CA, Sept. 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire...
Lowell Smokes Now Available Exclusively at Ascend in Massachusetts
Lowell Smokes initially available at Ascend Friend Street in downtown Boston in advance of statewide launch later this fallSALINAS, Calif.,...
Better Choice Announces Participation in the Jefferies Virtual Pet Summit on September 16th
NEW YORK, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (the “Company” or “Better Choice”), an animal...
TRACON Pharmaceuticals to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit
SAN DIEGO, Sept. 13, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the...
Outlook Therapeutics Presents Positive NORSE THREE Safety Data for ONS-5010 / LYTENAVA™ (bevacizumab-vikg) at EURETINA Virtual 2021 Medical Conference
ISELIN, N.J., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to develop and launch...
Collegium Announces Four Posters Presented at PAINWeek 2021 National Conference
STOUGHTON, Mass., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being...
Galecto Announces First Patient Treated in Phase 2 Trial of Oral Galectin-3 Inhibitor GB1211 in Liver Cirrhosis
Galecto now has three ongoing Phase 2 clinical trials with three different drug candidates in three high value indicationsBOSTON, Sept....
Aadi Bioscience Appoints Emma Reeve to its Board of Directors
LOS ANGELES, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (“Aadi”) (Nasdaq: AADI), a clinical-stage biopharmaceutical company focusing on...
Brooklyn ImmunoTherapeutics to Conduct Shareholder Update Conference Call on Monday, September 20, 2021, at 4:30 PM ET
BROOKLYN, N.Y., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on...
Intercept Pharmaceuticals Announces Convertible Notes Repurchase
NEW YORK, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) (“Intercept”), a biopharmaceutical company focused on the development...
Casma Therapeutics Announces Addition of Sharon Tooze, Ph.D. to Scientific Advisory Board
CAMBRIDGE, Mass., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Casma Therapeutics, Inc., a biotechnology company harnessing the process of autophagy to...
BetterLife to Present at the Emerging Growth Conference on September 15, 2021
VANCOUVER, British Columbia, Sept. 13, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an...
Additional Data from Hepion Pharmaceuticals’ Phase 2a ‘AMBITION’ Trial Further Strengthens CRV431 Clinical Profile and Paves Way for Initiation of Phase 2b ‘ASCEND-NASH’ Clinical Program
Pro-C3 and ALT reductions point to anti-inflammatory and antifibrotic effects of CRV431PK-PD models successfully predict early reductions in Pro-C3 and...
Pharma Two B Announces Last Patient Out in Phase III Study of P2B001 in Early Parkinson’s Disease
REHOVOT, Israel, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Pharma Two B Ltd., a privately held company developing innovative therapeutics based...
Spectral Medical’s CMO Recognized as a World Expert in Sepsis; Supports World Sepsis Day and Sepsis Awareness Month
Spectral Sponsors Live Webinar hosted by its CMO at the Sepsis Alliance Symposium September 13th is World Sepsis Day; September...
